This is out Library. Please click on the article title to view the details.
submitted by: admin on 05/07/2015
Both Germany and France have taken Actos off the market because of an increased risk of getting bladder cancer. The US is taking no action. Global sales of Actos are in the vicinity of $5 billion annually. All three "glitazone" drugs for type 2 diabetes have a poor track record. Rezulin was taken off the market more than a decade ago because it caused...
submitted by: admin on 05/07/2015
Drugs that increase the sensitivity of insulin in theory should be effective in preventing and treating type 2 diabetes. However, the glitazone drugs have turned out to have serious side effects that limit their use in clinical practice. The drug, Actos, is the one glitazone that could possibly be safe and effective in both the prevention and treatment...
submitted by: admin on 09/19/2013
Spanish researchers reported in the January 2013 issue of the American Journal of Clinical Nutrition that there are more than 700 species of bacteria in normal human breast milk. They suggest that this is one of the factors leading to which bacteria will colonize the infant's digestive tract.
Mother's milk is primarily lactose, but it is...
submitted by: admin on 10/09/2013
Patients with COPD who use inhaled corticosteroids to improve breathing for more than 6 months have a 27% increased risk for bone fractures. The risk goes up as the dosage increases. It was previously assumed that inhaled steroids would have a predominantly local effect, but now we know this is not true. Treatment should consist of lowering or discontinuing inhaled...
submitted by: admin on 10/09/2013
"Does every body need milk?" Despite concerns over saturated fats in dairy products such as milk and cheese in your diet, dairy products might not have as much affect on your health as you think according to some Dutch researchers. They found that there is no relationship between men’s dairy intake and risk of dying. Women with...
submitted by: admin on 10/11/2013
The Journal of the National Cancer Institute in August published an article showing that both Avandia and Actos increase bladder cancer by more than 400% compared to baseline incidence in diabetics. These drugs account for more than 20% of all drugs used to treat type 2 diabetes. Actos ranks 9th in the sales of all pharmaceutical drugs. This is remarkable...